Financials Mentice AB

Equities

MNTC

SE0012673291

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm 03:50:40 2024-04-30 am EDT 5-day change 1st Jan Change
35.6 SEK -0.84% Intraday chart for Mentice AB -6.81% -25.37%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,775 2,065 2,442 966.5 1,220 917.9 - -
Enterprise Value (EV) 1 1,742 2,028 2,444 935.9 1,170 838.9 806.3 750.2
P/E ratio -70 x -155 x -83.6 x -31 x -434 x 46 x 22.3 x 14.4 x
Yield - - - - - - - -
Capitalization / Revenue 11.9 x 15 x 13.2 x 4.43 x 4.46 x 2.74 x 2.23 x 1.86 x
EV / Revenue 11.7 x 14.7 x 13.2 x 4.29 x 4.28 x 2.5 x 1.96 x 1.52 x
EV / EBITDA -135 x -495 x 978 x -240 x 48.4 x 16.2 x 10.3 x 6.98 x
EV / FCF - 390 x -78.8 x 505 x 39.6 x 28.4 x 24.7 x 13.4 x
FCF Yield - 0.26% -1.27% 0.2% 2.52% 3.52% 4.05% 7.44%
Price to Book 14.1 x 12.6 x 17.8 x 5.94 x 7.67 x 5.07 x 4.13 x 3.25 x
Nbr of stocks (in thousands) 24,147 24,728 24,769 25,569 25,569 25,569 - -
Reference price 2 73.50 83.50 98.60 37.80 47.70 35.90 35.90 35.90
Announcement Date 2/27/20 2/4/21 2/3/22 2/3/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 149.4 137.5 185.1 218 273.6 335.4 412.1 494.7
EBITDA 1 -12.9 -4.1 2.5 -3.9 24.2 51.75 78.38 107.5
EBIT 1 -24.48 -18.21 -19.72 -23.95 -0.679 24.85 50.25 77.93
Operating Margin -16.38% -13.25% -10.65% -10.99% -0.25% 7.41% 12.2% 15.75%
Earnings before Tax (EBT) 1 -26.24 -18.59 -21.27 -24.04 -0.013 24.96 50.4 78.46
Net income 1 -20.6 -13.1 -29.2 -30.66 -2.817 20.25 40.94 63.45
Net margin -13.79% -9.53% -15.78% -14.07% -1.03% 6.04% 9.93% 12.82%
EPS 2 -1.050 -0.5400 -1.180 -1.220 -0.1100 0.7803 1.607 2.492
Free Cash Flow 1 - 5.196 -31.03 1.854 29.53 29.5 32.67 55.8
FCF margin - 3.78% -16.76% 0.85% 10.79% 8.79% 7.93% 11.28%
FCF Conversion (EBITDA) - - - - 122.02% 57% 41.68% 51.89%
FCF Conversion (Net income) - - - - - 145.67% 79.8% 87.95%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/27/20 2/4/21 2/3/22 2/3/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 38.67 67.7 53.08 45.11 51.1 68.66 64.96 74.31 63.9 70.43 78.25 82.75 81.25 91.65
EBITDA 1 -0.6 12 -1.3 -12.2 -1.9 11.5 7.3 10.7 4 2.3 8.728 10.9 10.96 20.49
EBIT 1 -5.788 4.019 -6.082 -17.22 -7.255 6.602 0.103 4.822 -2.043 -3.561 1.978 4.148 4.213 13.24
Operating Margin -14.97% 5.94% -11.46% -38.17% -14.2% 9.62% 0.16% 6.49% -3.2% -5.06% 2.53% 5.01% 5.19% 14.45%
Earnings before Tax (EBT) 1 -6.521 3.075 -6.935 -16.75 -7.37 7.018 -0.632 4.771 -1.696 -2.455 2.103 6.474 6.624 12.69
Net income 1 -7.231 -4.2 -7.425 -17.64 -7.746 2.143 -1.483 1.473 0.016 -2.823 1.82 3.525 3.583 10.45
Net margin -18.7% -6.2% -13.99% -39.1% -15.16% 3.12% -2.28% 1.98% 0.03% -4.01% 2.33% 4.26% 4.41% 11.4%
EPS 2 -0.2900 -0.1700 -0.3000 -0.7100 -0.3000 0.0800 -0.0600 0.0600 - -0.1100 0.0642 0.1975 0.2021 0.3871
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 10/28/21 2/3/22 4/27/22 7/21/22 10/26/22 2/3/23 4/27/23 7/20/23 10/26/23 2/15/24 - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 2.01 - - - - -
Net Cash position 1 32.6 37.2 - 30.6 49.6 79.1 112 168
Leverage (Debt/EBITDA) - - 0.8028 x - - - - -
Free Cash Flow 1 - 5.2 -31 1.85 29.5 29.5 32.7 55.8
ROE (net income / shareholders' equity) - -9.09% -19.5% -20.5% -1.75% 12% 20.6% 25.1%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 5.200 6.600 5.530 6.360 6.220 7.080 8.690 11.00
Cash Flow per Share - - - - - - - -
Capex 1 - 25.3 25.9 13.1 6.99 14.9 17.3 19.3
Capex / Sales - 18.43% 13.99% 5.99% 2.55% 4.44% 4.2% 3.89%
Announcement Date 2/27/20 2/4/21 2/3/22 2/3/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.9 SEK
Average target price
55.33 SEK
Spread / Average Target
+54.13%
Consensus